Biogen Seeks Approval For New Alzheimer’s Drug

Biogen is developing a drug to fight Alzheimer’s, a disease that scientists have struggled to treat for decades. U.S. outside advisors to the Food and Drug Administration (FDA) will review the drug aducanumab and are expected to reach a final decision by March 7th...